AVENUE SOLUTIONS for EXPRESS SCRIPTS INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to Medicare/Medicaid drug coverage including pharmacy payments (average manufacturer price), reimbursements, competition and plan administration, electronic prescribing, chronic care, PBM disclosure. HR 3200, America's Affordable Health Choices Act; HR 3590, Patient Protection and Affordable Care Act; HR 3962, Affordable Health Care for America Act - health reform proposals impacting prescription drug coverage including formulary requirements, generic drug co-payments,direct negotiation, Medicare/Medicaid rebate changes, closure of Part D coverage gap, retiree drug subsidy, pharmaceutical benefit manager excise tax, medication therapy management
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH MACDONALD BARNETT | — |
| TRACY SPICER | — |
| AMY TEJRAL | — |
Pharmacy PHA
HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 1427, Promoting Innovation and Access to Life Saving Medicine Act - generic biologics; HR 1548, Pathway for Biosimilars Act - generic biologics; HR 1706, Protecting Consumer Access to Generic Drugs Act - generic drugs; HR 3200, America's Affordable Health Choices Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data minimg, pharmaceutical benefit manager excise tax, generic biologics; HR 3590, Patient Protection and Affordable Care Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics; HR 3962, Affordable Health Care for America Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics, generic prescription drugs; HR 4489, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act HR 4872, Health Care and Education Reconciliation Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics; S. 369, Preserve Access to Affordable Generics Act - generic drugs; S 726, Promoting Innovation and Access to Life-Saving Medicine Act - generic biologics; S 1630, Affordable Access to Prescription Medications Act - prescription drug co-pays and formularies; S 1679, Affordable Health Choices Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics; S 1796, American's Healthy Future Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH MACDONALD BARNETT | — |
| TRACY SPICER | — |
| AMY TEJRAL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.